Unresectable Malignant Solid Neoplasm Active Not Recruiting Phase 1 Trials for Cediranib (DB04849)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0110416 (Unresectable Malignant Solid Neoplasm) | Active Not Recruiting | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01364051 | Cediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid Malignancies | Treatment |